SLOs:

• Compare and contrast mammography, ultrasound, and MRI

• Apply appropriate screening intervals based on the new recommendations starting at age 40

• Discuss false positive/negative rates of screening methods

• Create a diagnostic plan for a newly discovered breast mass

• Implement evidence-based treatments for breast pain

• Identify and manage endocrine causes of galactorrhea

General Instructions:

In this activity, you will demonstrate your understanding of breast cancer screening principles and management of benign breast findings through critical analysis of current guidelines and application to clinical scenarios.

Step 1: Select and Reflect

•  First, review the slide sets on "Breast Cancer Screening Principles" and "Management of Benign Breast Findings." These will provide you with foundational knowledge about screening modalities and approaches to common breast complaints.

•  Then read the 2024 USPSTF breast cancer screening guidelines and the accompanying evidence review.

•  Also review the article "Comparative Effectiveness of Breast Cancer Screening Modalities" and "Management of Common Breast Findings: An Evidence-Based Approach."

•  You may also wish to review additional resources on breast cancer screening and diagnostic approaches for a more comprehensive understanding.

Step 2: Critical Analysis and Response

Based on your readings and research, compose a 700-900 word response addressing the following:

1. Critically analyze the 2024 USPSTF breast cancer screening guidelines, including the rationale for starting routine screening at age 40. Compare these recommendations with those of at least two other professional organizations (e.g., American Cancer Society, American College of Radiology, etc.). Explain differences in recommended screening intervals and identify the evidence these organizations prioritize when forming their guidelines. 

2. Compare and contrast mammography, ultrasound, and MRI in both screening and diagnostic contexts. In your analysis, discuss sensitivity, specificity, false-positive and false-negative rates, cost-effectiveness, and clinical scenarios in which one modality is preferred over the others. 

3. Case study 1: You are evaluating a 45-year-old woman with a newly discovered 1.5 cm palpable breast mass. Outline a comprehensive step-by-step diagnostic plan that reflects current guidelines. Include specific imaging selection and sequencing, clear indications for biopsy, and any relevant risk-based considerations. Your plan should demonstrate a systematic approach from initial evaluation through definitive diagnosis.

4. Case study 2: A separate patient presents with noncyclic breast pain and scant milky nipple discharge. Identify endocrine causes of galactorrhea (including prolactinomas, hypothyroidism, and medication-induced causes) and describe your diagnostic and management approach, including appropriate laboratory evaluation (prolactin levels, TSH, comprehensive medication review) and evidence-based pharmacologic and non-pharmacologic treatments for breast pain.

• Briefly discuss the ethical considerations associated with breast cancer screening programs, including overdiagnosis, overtreatment, and psychological distress associated with false positives. Propose 2 evidence-based strategies to mitigate these harms while preserving early-detection benefits.

Step 3: Share

To share your work, click on the "Add a new discussion topic" button under this post and paste your work into the "Message" box. Make sure to reference others' intellectual property when necessary. All references should follow 7th Edition APA formatting. For further instructions, see the resource on the Himmelfarb Health Sciences Library: APA citation resource (N.B.: references are excluded from word counts).